AEXYRA BIO

{
  "notary": {
    "name": "Jean-Michel GAUTHY",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Herstal",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-05-28",
    "filing_date": "2026-05-26",
    "act_kind_objet": "Objet de l\u0027acte:",
    "is_private_deed": false
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2026-05-26",
    "unanimous": true
  },
  "founders": [
    {
      "org": {
        "kbo": "0719.281.031",
        "name": "Bringing Mind 2 Business",
        "address": "4630 Soumagne, Rue de la Haisse 1",
        "country": "BE",
        "legal_form": "SRL",
        "foreign_register_name": null,
        "foreign_register_number": null
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 150.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 450090,
      "amount_subscribed_eur": 150.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0719.278.457",
        "name": "VOX SUALEM",
        "address": "4000 Li\u00E8ge, avenue de la Laiterie 6",
        "country": "BE",
        "legal_form": "SRL",
        "foreign_register_name": null,
        "foreign_register_number": null
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 150.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 450090,
      "amount_subscribed_eur": 150.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "0552.855.260",
        "name": "ILUSA",
        "address": "4000 Li\u00E8ge, Avenue de la Laiterie 6",
        "country": "BE",
        "legal_form": "SRL",
        "foreign_register_name": null,
        "foreign_register_number": null
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 300000.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 299970,
      "amount_subscribed_eur": 300000.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": "1038.241.478",
        "name": "Berking Holding UG",
        "address": "22547 Hamburg, Luruper Haupstrasse 1",
        "country": "DE",
        "legal_form": "UG",
        "foreign_register_name": "Handelsregister Hamburg",
        "foreign_register_number": "HRB 181790"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 1350000,
      "amount_subscribed_eur": 450.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1982-06-15",
        "name": "KRAMER Vasko",
        "niss": null,
        "address": "6006 Luzern, W\u00FCrzenbachmatte 33",
        "nationality": "Allemagne",
        "place_of_birth": "Hamburg, Allemagne"
      },
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 0.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 149850,
      "amount_subscribed_eur": 50.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "voorwerp": {
    "full_text": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u2019\u00E0 l\u2019\u00E9tranger, pour elle-m\u00EAme ou pour le compte de tiers ou en participation avec des tiers :\n- la recherche, le d\u00E9veloppement, la production, la commercialisation et l\u2019exploitation de produits biologiques, biotechnologiques, diagnostiques, th\u00E9rapeutiques et pharmaceutiques ;\n- le d\u00E9veloppement d\u2019anticorps, nanocorps (VHH), prot\u00E9ines recombinantes, biologiques d\u00E9riv\u00E9s du venin, plateformes immunologiques et technologies apparent\u00E9es ;\n- le d\u00E9veloppement de diagnostics rapides, tests de d\u00E9tection, technologies de biod\u00E9fense et solutions de surveillance \u00E9pid\u00E9miologique ;\n- la recherche et le d\u00E9veloppement dans le domaine des maladies infectieuses, antivirales, pand\u00E9miques et zoonotiques ;\n- la gestion, l\u2019acquisition, la concession, la sous-licence et l\u2019exploitation de droits de propri\u00E9t\u00E9 intellectuelle ;\n- toutes activit\u00E9s de consultance scientifique, r\u00E9glementaire, industrielle ou strat\u00E9gique ;\n- la conception, le d\u00E9veloppement, la gestion et la maintenance de plateformes technologiques assist\u00E9es par intelligence artificielle et/ou par des outils computationnels ;\n- le d\u00E9veloppement de th\u00E9rapies biologiques, cellulaires, g\u00E9niques ou d\u00E9riv\u00E9es d\u2019acides nucl\u00E9iques ;\n- la prise de participations dans toute soci\u00E9t\u00E9 ou entreprise li\u00E9e directement ou indirectement \u00E0 son objet ;\nTout cela au sens le plus large possible, en ce compris les activit\u00E9s annexes.\nLa soci\u00E9t\u00E9 peut accomplir toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques, y compris financi\u00E8res ou immobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet.\nElle peut s\u0027int\u00E9resser par toutes voies dans toutes affaires, entreprises ou soci\u00E9t\u00E9s ayant un objet identique, similaire ou connexe, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u0027\u00E9coulement de ses produits.\nLa soci\u00E9t\u00E9 peut \u00E9galement conc\u00E9der des s\u00FBret\u00E9s personnelles et/ou r\u00E9elles en faveur de tiers, personnes physiques ou morales.\nElle peut exercer les fonctions d\u2019administrateur ou de liquidateur d\u2019autres soci\u00E9t\u00E9s.",
    "is_lucrative": true,
    "short_summary": "Recherche, d\u00E9veloppement, production, commercialisation et exploitation de produits biologiques, biotechnologiques, diagnostiques, th\u00E9rapeutiques et pharmaceutiques, ainsi que de technologies associ\u00E9es."
  },
  "governance": {
    "organ_kind": "raad_van_bestuur",
    "n_directors_max": null,
    "n_directors_min": 1,
    "representation_clause": "deux administrateurs conjointement",
    "co_signature_threshold_eur": 10000.0
  },
  "fiscal_year": {
    "end_mm_dd": "12-31",
    "start_mm_dd": "01-01",
    "first_exercise_end_date": "2027-12-31",
    "is_prolonged_first_exercise": true
  },
  "agm_schedule": {
    "time": "10:00",
    "month": 6,
    "rule_text": "troisi\u00E8me mardi du mois de juin"
  },
  "founding_event": {
    "n_shares_total": 2700000,
    "n_share_classes": 1,
    "bank_attestation": null,
    "amount_paid_in_eur": 300300.0,
    "incorporation_date": "2026-05-26",
    "amount_subscribed_eur": 300300.0,
    "art_5_8_no_payment_due": false,
    "pre_incorporation_activity_from_date": "2026-05-01"
  },
  "subject_company": {
    "kbo": "1038.299.282",
    "email": null,
    "region": "waals_gewest",
    "website": null,
    "name_full": "AEXYRA BIO",
    "legal_form": "SRL",
    "name_abbreviated": null,
    "zetel_address_raw": "Boulevard Fr\u00E8re Orban 46, 4000 Li\u00E8ge",
    "equity_account_type": "available"
  },
  "initial_directors": [
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": "0719.281.031",
        "name": "Bringing Mind 2 Business",
        "legal_form": "SRL"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "WOUTERS Ludovic Marie Michel",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": "0719.278.457",
        "name": "VOX SUALEM",
        "legal_form": "SRL"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "VOCCIA Sam\u00FCel",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    },
    {
      "kind": "rechtspersoon",
      "person": null,
      "via_org": {
        "kbo": "1038.241.478",
        "name": "Berking Holding UG",
        "legal_form": "UG"
      },
      "role_sub": "bestuurder",
      "mandate_until": {
        "kind": "indefinite",
        "value": null
      },
      "rep_person_name": "ROJAS-FERNANDEZ Alejandro",
      "additional_roles": [],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    }
  ],
  "co_filed_documents": [
    "expedition",
    "statuten"
  ],
  "post_incorporation_mandates": [
    {
      "kind": "volmacht_kbo",
      "holder_org_kbo": "0719.281.031",
      "holder_org_name": "Bringing Mind 2 Business",
      "with_substitution": false,
      "holder_person_name": null
    },
    {
      "kind": "volmacht_kbo",
      "holder_org_kbo": "0719.278.457",
      "holder_org_name": "VOX SUALEM",
      "with_substitution": false,
      "holder_person_name": null
    },
    {
      "kind": "volmacht_kbo",
      "holder_org_kbo": "1038.241.478",
      "holder_org_name": "Berking Holding UG",
      "with_substitution": false,
      "holder_person_name": null
    }
  ]
}